research and development
SCM Pharma appoints Adam Sims
July 5, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Sterile filling specialist SCM Pharma has bolstered its senior management team with the appointment of Adams Sims as a non-executive …
Almirall appoints new general manager for Germany
July 1, 2011Research and Development, Sales and Marketing Almirall, appointment, research and development, sales and marketing
Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …
Sanofi appoints Peter Guenter senior VP, Europe
June 28, 2011Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing
Sanofi has promoted Peter Guenter to senior vice president, Europe, with effect from 15 July. He is currently general manager …
John Burt takes on leadership of PolyTherics
June 23, 2011Research and Development appointment, research and development
PolyTherics has promoted John Burt from chief business officer to chief executive.Prior to joining PolyTherics, which applies precision chemistry to …
Biocair appoints new business development managers
June 16, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Biocair has appointed two new business development managers, Natalie Gerrard and Steve Taylor. Natalie Gerrard was promoted internally from within …
Xceleron appoints Dr Stuart Best
June 14, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Dr Stuart Best has joined Xceleron as senior director operations, moving to the company from Merck in Scotland where he …
Daniel Elger joins e-Therapeutics
June 13, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
UK and India-based e-Therapeutics has appointed Dr Daniel Elger as chief financial officer. He joins the drug discovery company from …
Lilly promotes Andrew Hotchkiss
June 9, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Lilly has appointed Andrew Hotchkiss president of its operations in Australia, Canada and Europe. Andrew has been with the company …
Oxford BioMedica appoints Alex Lewis to strategy role
June 8, 2011Research and Development appointment, research and development
Oxford, UK-based gene therapy company Oxford BioMedica has appointed Dr Alex Lewis as director of corporate activities and strategy, and …
Mark Dean-Netscher joins Penn Pharma
May 18, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer. He has more than 20 years experience in …
Service Insight: Clinical trials – managing route to market
May 11, 2011Research and Development Service Insight, Talking Point, research and development
SERVICE INSIGHT Clinical trials are notoriously difficult to manage and often fraught with problems, as they can involve many clinical …
Thomas Lingelbach appointed chief executive of Intercell
May 5, 2011Research and Development appointment, research and development
Vienna-based biotech Intercell has appointed Thomas Lingelbach as chief executive with effect from 10 May. He has more than twenty …
Contract research news in brief
May 4, 2011Research and Development contract research, cros, research and development
This week’s CRO news roundup includes Omnicare CR and LAB Research changing hands, Q1 financials for ICON and PPD and …
Astellas adds senior executives to global development team
May 4, 2011Research and Development appointment, research and development
Astellas Pharma has made four new senior appointments to its US-based global development team. Former Eli Lilly vice president of …
Service Insight: Due diligence in emerging markets for clinical development
May 4, 2011Research and Development Service Insight, Talking Point, research and development
SERVICE INSIGHT Currently, the pharma industry is experiencing an unprecedented wave of blockbuster drug patent expiries. There is a lack …
Latest content
Five Facts about cardiovascular disease
